<DOC>
	<DOCNO>NCT01189461</DOCNO>
	<brief_summary>This study asses sthe safety pegaptanib sodium patient diabetic macular edema . The hypothesis pegaptanib safe efficacious patient diabetic macular edema .</brief_summary>
	<brief_title>Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Subjects document clinical diagnosis diabetic macular edema ( DME ) proliferative non proliferative diabetic retinopathy . Subjects , accord clinical assessment investigator , may benefit antiVEGF therapy include subject participate A5751013 study , investigator 's opinion , may benefit continued pegaptanib sodium therapy . Eyes prior scatter ( panretinal ) photocoagulation within 4 month prior baseline anticipate scatter ( panretinal ) photocoagulation within next 6 month . Presence abnormality likely confound assessment visual acuity improvement eye macular edema resolve , improves , nonperfusion &gt; 1 disc area involve foveal avascular zone ( FAZ involve 2 quadrant center around foveal avascular zone ) , epiretinal membrane associate sign contraction and/or significant opacification ( i.e . stria within 1 disc diameter foveal center ) , presence chorioretinal atrophy involve center macula . Vitreomacular traction determine clinically and/or optical coherence tomography ( OCT ) , , investigator 's opinion , contribute macular edema ( cause associate foveal detachment ) , would preclude improvement pegaptanib sodium . Any cause macular edema vitreous extension , entrapment anterior segment wound , retinal vein occlusion involve macula .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>pegaptanib sodium</keyword>
	<keyword>diabetic macular edema</keyword>
</DOC>